Health Wire Syria: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Syria.

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Press releases published on January 6, 2026

January 6, 2026

Visory Health Named to Inc.’s Best in Business for Excellence in Social Good

GlobeNewswire

January 6, 2026

Alpha Tau Reports New Positive Results in Two Upcoming Presentations at ASCO GI 2026 Symposium Showcasing Immune-Preservation and High Disease Control in Montreal Pancreatic Cancer Alpha DaRT® Study

GlobeNewswire

January 6, 2026

Autolus Therapeutics to Evaluate Automated Manufacturing of AUCATZYL® (obe-cel) on the Cellares Cell Shuttle™ Platform

GlobeNewswire

January 6, 2026

Clever Care Health Plan and CareMore Health Launch New Partnership to Expand Access to Care in Southern California

GlobeNewswire

January 6, 2026

Medical AI Expert Wido Menhardt Joins FemPulse Scientific Advisory Board

GlobeNewswire

January 6, 2026

J-Star Announces Strategic Plan to Exit China and Accelerate Expansion in the United States

GlobeNewswire

January 6, 2026

2026 New Year’s Greetings from the CEO

GlobeNewswire

January 6, 2026

YD Bio Enters into MOU to Merge with EG BioMed, Advancing DNA Methylation–Driven AI Platforms for Cancer Diagnostics and Drug Development

GlobeNewswire

$Actuate Therapeutics Announces Positive Patient Outcomes from Phase 1 Trial in Difficult-to-Treat Refractory Pediatric Cancers$

January 6, 2026

Actuate Therapeutics Announces Positive Patient Outcomes from Phase 1 Trial in Difficult-to-Treat Refractory Pediatric Cancers

GlobeNewswire

January 6, 2026

Prestigious Research University Integrates SteraMist Hybrid System for Advanced Medical Product Sterilization

GlobeNewswire

January 6, 2026

Insight Timer Launches New Year’s Resolution and Intention-Setting Features with AI Recommendation Engine

GlobeNewswire

January 6, 2026

Outlook Therapeutics Appoints Laura Cantrell as Vice President of Corporate Strategy and Business Development

GlobeNewswire

January 6, 2026

Milestone Scientific Launches The Wand® Ambassador Program to Expand Peer Engagement and Accelerate Market Adoption in Dentistry

GlobeNewswire

January 6, 2026

Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026

GlobeNewswire

January 6, 2026

CVRx Announces Implementation of New Category I CPT Codes for Barostim Therapy

GlobeNewswire

January 6, 2026

SS Innovations Develops New Instruments to Advance Robotic Surgery in Large, Underserved Patient Segments, including Pediatric and Cardiac Markets

GlobeNewswire

January 6, 2026

FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference

GlobeNewswire

January 6, 2026

LifeMD Announces Closing of $50 Million Revolving Credit Facility with Citizens Bank, N.A.

GlobeNewswire

January 6, 2026

Coeptis Therapeutics S-4 Declared Effective by SEC, Proxy Mailing Begins in Anticipation of the Merger Transaction with Z Squared

GlobeNewswire

January 6, 2026

Ernexa Therapeutics Announces Successful Pre-IND FDA Meeting and Continues Progress Toward First-in-Human Trial in Ovarian Cancer

GlobeNewswire